News
2019
-
-
Sysmex Presents Academic Report with a View to Creating a Simple Method of Diagnosing Alzheimer’s Disease Using Blood
- Presenting the Most Recent Data at the 12th Clinical Trials on Alzheimer’s Disease (CTAD) Conference -
-
-
Sysmex Presents Academic Report with a View to Creating a Simple Method of Diagnosing Alzheimer’s Disease Using Blood
-Presenting the Most Recent Data at the 12th Clinical Trials on Alzheimer’s Disease (CTAD) Conference-
-
-
Summary of Consolidated Financial Results for the First Six Months of the Fiscal Year Ending March 31, 2020 (PDF：374KB)
-
-
Announcement Regarding Differences between Actual and Forecast Figures for the Six Months Ended September 30, 2019, and Revision of Full-Year Financial Forecasts (PDF：228KB)
-
-
Sysmex Wins Awards in 2019 Kinki Local Commendations for Innovations
-
-
Sysmex and OPTiM Reach a Basic Agreement on the Establishment of a Joint Venture to Accelerate the Commercialization of Digital Medicine to Support Next-Generation Healthcare and Diagnostics
-Aiming toward the Early-Stage Provision of Platforms and Applications Related to Digital Medicine-
-
-
Industry, Government and Academia Jointly Establish a General Incorporated Association to Promote the Bioresource Business
-Jointly Established by Kobe University, the City of Kobe, the Foundation for Biomedical Research and Innovation at Kobe, and Sysmex-
-
-
Development of a Fully Automated Measurement Method for Soluble Immune Checkpoint Molecules (sPD-1, sPD-L1 and sCTLA-4)
-
-
Notice of Decisions on the Details of Stock Option Issuance (PDF：170KB)
-
-
Sysmex Launches Caresphere™ QM, an Operational Support System for Testing Quality Management
-Realizing the Operation of High-Quality Clinical Laboratories through our New Caresphere™ Solution-
-
-
Sysmex Selected for Inclusion in the Dow Jones Sustainability World Index for the Fourth Consecutive Year
-
-
Japan’s First Automated Hematology Analyzer Registered by the National Museum of Nature and Science as “Essential Historical Material for Science and Technology”
-Using Unique Technology to Cultivate True Automation in Blood Cell Counting-
-
-
Issuance of Stock Options (Stock Acquisition Rights) (PDF：201KB)
-
-
Sysmex Launches its Sample Preparation System PS-10 in North America, a New Product to Make Clinical Flow Cytometry Testing More Efficient
-
-
Summary of Consolidated Financial Results for the First Three Months of the Fiscal Year Ending March 31, 2020 (PDF：347KB)
-
-
Sysmex Obtains First Manufacturing and Marketing Approval in Japan for Blood-Based RAS Gene Mutation Testing for Colorectal Cancer
-
-
Sysmex Receives the 44th Inoue Harushige Prize
-
-
Our Views and Policy regarding Investment Unit Reduction (PDF：81KB)
-
-
World Anti-Doping Agency Coordinates Global Implementation of Sysmex Analyzers at All Blood Laboratories
-Contributing to Clean and Fair Sports Management by Enhancing the Quality of Doping Tests-
-
-
The OncoGuide™ NCC Oncopanel System Receives Insurance Coverage for Use in Cancer Genome Profiling
-
-
Sysmex and Osaka University Sign Comprehensive Collaboration Agreement to Foster Innovation in the Healthcare Field
-
-
Summary of Consolidated Financial Results for the Fiscal Year Ended March 31, 2019 (PDF：389KB)
-
-
Sysmex Announces Changes from Financial Forecasts and Year-End Dividend for the Fiscal Year Ended March 31, 2019 (PDF：59KB)
-
-
Notice of the Booking of an Extraordinary Loss (Non-Consolidated) in Relation to an Affiliated Company (PDF：27KB)
-
-
Announcement Related to Granting of Stock Options (Stock Acquisition Rights) as a Part of Compensation to Members of the Managing Board (PDF：89KB)
-
-
Announcement of Executive Change (PDF：130KB)
-
-
Sysmex Announces New Group Mid-Term Management Plan
-Working to Enhance the Group’s Growth Potential and Reinforce the Management Base with a View to Sustainable Growth- (PDF：117KB)
-
-
Sysmex Opens Technopark East Site, a Bio-Diagnostic Reagent Base
-Strengthening Diagnostic Reagent Functions through an Integrated Structure from the Development of Substances to the Development, Production and Distribution of Bio-Diagnostic Reagents-
-
-
Promoting Business Process Restructuring through Digitalization to Reinforce Corporate Foundations and Create New Value
-
-
Sysmex Obtains CE Certification for Automated Hematology Analyzer XN-31, Which Has an Automatic Measurement Function for Red Blood Cells Infected by Malaria Parasites
-Contributing to the Early Detection and Treatment of Malaria through Standardized and More Efficient Malaria Testing-
-
-
Sysmex and Bayer Yakuhin Sign Memorandum of Understanding to Jointly Promote Open Innovation
-Start of Collaboration toward the Formation of an Ecosystem in the Life Science Field in Kobe-
-
-
Sysmex Launches Caresphere™ LWS, a Laboratory Information System
-Further Enhancing Clinical Testing Efficiency through a New Caresphere™ Solution-
-
-
Announcement of Organizational and Personnel Changes (PDF：322KB)
-
-
Sysmex to Be Special Sponsor of the Kobe Marathon 2019
-We are pleased to have sponsored this exciting event since its inception in 2011-
-
-
Commencement of Assay Service Using the OncoGuide™ NCC Oncopanel System in Cancer Genome Profiling
-
-
FY2018 Nakatani Award and Research Grant Recipients Announced (PDF：102KB)
-
-
Summary of Consolidated Financial Results for the First Nine Months of the Fiscal Year Ending March 31, 2019 (PDF：381KB)
-
-
Sysmex and OPTiM Enter Alliance in the Area of “Advanced Medicine x AI and IoT”
-Accelerating Development and Deployment of IT Solutions and Platforms to Support Next-Generation Healthcare and Diagnostics-
